RT @Ablate_Cancer: Conclusion: Pivotal testing of single agent PV-10 is ongoing. Conclusion of Phase 1b testing of PV-10 in combination w c…
17 followers
1,446 followers
Conclusion: Pivotal testing of single agent PV-10 is ongoing. Conclusion of Phase 1b testing of PV-10 in combination w checkpoint inhibition is anticipated to lead to Phase 2 randomized testing in 2018. $pvct #immunotherapy #PV-10 #melanoma (pages 14-15) h
2,878 followers
RT @lifebiomedguru: Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts https://t.co/dqdaxEcrRV
46,864 followers
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts https://t.co/dqdaxEcrRV